₹ 2.9 Cr
Volume Transacted
(Jan 13, 2025)
4.1 K
Stocks Traded
(Jan 13, 2025)
Last Updated on: Jan 14, 2025
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
13 Jan 2025 | 7043.7 | 6809.8 | 7199.9 | 6769.55 |
10 Jan 2025 | 6912.5 | 7040 | 7040 | 6854.95 |
09 Jan 2025 | 7076 | 6946.9 | 7518.3 | 6946.9 |
08 Jan 2025 | 6892.55 | 7050 | 7069.9 | 6851.2 |
07 Jan 2025 | 7092.85 | 7275.45 | 7384.4 | 7011 |
06 Jan 2025 | 7251.75 | 7173 | 7392.75 | 6910.6 |
03 Jan 2025 | 7113.75 | 7173.95 | 7194.9 | 7009.9 |
02 Jan 2025 | 7137.75 | 7220 | 7220 | 7112 |
01 Jan 2025 | 7206.4 | 7007.05 | 7380.55 | 7007.05 |
31 Dec 2024 | 7309.8 | 7185.85 | 7547.35 | 7062.05 |
Date | Price (₹) |
---|---|
13 Jan 2025 | 7043.7 |
10 Jan 2025 | 6912.5 |
09 Jan 2025 | 7076 |
08 Jan 2025 | 6892.55 |
07 Jan 2025 | 7092.85 |
06 Jan 2025 | 7251.75 |
03 Jan 2025 | 7113.75 |
02 Jan 2025 | 7137.75 |
01 Jan 2025 | 7206.4 |
31 Dec 2024 | 7309.8 |
Volumes spurt at Astrazeneca Pharma India Ltd counter
Happiest Minds Technologies Ltd, Campus Activewear Ltd, Cera Sanitaryware Ltd, ITI Ltd are...
30 Dec 2024 14:30
AstraZeneca gets CDSCO nod to import cancer drug, Lynparza
This approval establishes the use of Olaparib in combination with Durvalumab as a maintena...
26 Nov 2024 14:49
AstraZeneca Pharma gains on plan to launch COPD drug
Earlier, on 2 December 2023, the pharma company intimated about the receipt of import and ...
19 Nov 2024 12:11
AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr
Revenue from operations jumped 31.16% year on year (YoY) to Rs 408 crore in the quarter en...
14 Nov 2024 12:34
Astrazeneca Pharma India to announce Quarterly Result
Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...
25 Oct 2024 16:11
Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...
24 Sep 2024 08:54
Unlimited trading starting at just Rs. 249*